8-K DEPARTURE OF DIRECTOR

Company

HALOZYME THERAPEUTICS, INC.

Filed

March 22, 2018

Period of Report

March 20, 2018

Accession Number

0001159036-18-000016

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →